LCM
PLRX icon

Laurion Capital Management’s Pliant Therapeutics PLRX Stock Holding History

Laurion Capital Management’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$520K Buy
412,796
+155,396
+60% +$196K 0.05% 290
2025
Q4 		$314K Buy
+257,400
New +$387K 0.02% 276
2024
Q3 		– Sell
-2,498,920
Closed -$26.9M – 548
2024
Q2 		$26.9M Sell
2,498,920
-975,824
-28% -$12.6M 0.88% 58
2024
Q1 		$51.8M Sell
3,474,744
-108,823
-3% -$1.8M 1.44% 49
2023
Q4 		$64.9M Buy
3,583,567
+397,056
+12% +$6.04M 2.33% 50
2023
Q3 		$55.3M Buy
3,186,511
+27,941
+0.9% +$484K 1.44% 69
2023
Q2 		$57.2M Buy
+3,158,570
New +$74.8M 2.46% 65
2022
Q3 		– Sell
-470,601
Closed -$3.77M – 608
2022
Q2 		$3.77M Buy
+470,601
New +$3.01M 0.16% 192

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $315M AUM 54.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return